全文获取类型
收费全文 | 10526篇 |
免费 | 492篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 140篇 |
儿科学 | 224篇 |
妇产科学 | 213篇 |
基础医学 | 2319篇 |
口腔科学 | 184篇 |
临床医学 | 707篇 |
内科学 | 1650篇 |
皮肤病学 | 197篇 |
神经病学 | 1268篇 |
特种医学 | 500篇 |
外科学 | 1238篇 |
综合类 | 35篇 |
一般理论 | 2篇 |
预防医学 | 592篇 |
眼科学 | 278篇 |
药学 | 907篇 |
2篇 | |
中国医学 | 9篇 |
肿瘤学 | 591篇 |
出版年
2021年 | 139篇 |
2020年 | 124篇 |
2019年 | 125篇 |
2018年 | 133篇 |
2017年 | 123篇 |
2016年 | 156篇 |
2015年 | 184篇 |
2014年 | 249篇 |
2013年 | 298篇 |
2012年 | 493篇 |
2011年 | 527篇 |
2010年 | 311篇 |
2009年 | 318篇 |
2008年 | 496篇 |
2007年 | 506篇 |
2006年 | 487篇 |
2005年 | 510篇 |
2004年 | 523篇 |
2003年 | 486篇 |
2002年 | 484篇 |
2001年 | 155篇 |
2000年 | 144篇 |
1999年 | 134篇 |
1998年 | 101篇 |
1997年 | 97篇 |
1996年 | 74篇 |
1995年 | 67篇 |
1994年 | 69篇 |
1993年 | 58篇 |
1992年 | 81篇 |
1991年 | 69篇 |
1990年 | 66篇 |
1989年 | 70篇 |
1988年 | 68篇 |
1985年 | 65篇 |
1941年 | 55篇 |
1940年 | 70篇 |
1939年 | 57篇 |
1938年 | 72篇 |
1937年 | 81篇 |
1936年 | 74篇 |
1935年 | 68篇 |
1934年 | 56篇 |
1932年 | 60篇 |
1930年 | 59篇 |
1928年 | 59篇 |
1925年 | 62篇 |
1924年 | 64篇 |
1923年 | 55篇 |
1922年 | 55篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Streibert Fridolin Bernhardt Claudia Simon Philipp Hilbert-Carius Peter Wrigge Hermann 《Der Anaesthesist》2023,72(1):57-62
Die Anaesthesiologie - Die Anlage einer Magensonde im OP oder auf einer Intensivstation (ITS) stellt eine alltäglich durchgeführte Prozedur dar. Obwohl die Sonde häufig durch... 相似文献
2.
3.
Andrea R Genazzani Hermann P G Schneider Nick Panay Esme A Nijland 《Gynecological endocrinology》2006,22(7):369-375
OBJECTIVES: To identify and describe current women's thoughts about the menopause, hormone treatment (HT) and perceptions about breast cancer. METHODS: Between December 2004 and January 2005, 4201 postmenopausal women in seven European countries were interviewed via a standardized computer-aided telephone interview protocol. RESULTS: Almost all women reported to have experienced climacteric symptoms, and 63% of the women rated them as being severe. Only 52% of women were aware of the benefits of HT for relief of climacteric symptoms. Although 84% felt that severe symptoms should be treated, only 40% had used HT at some point in time. Thirty-four percent of the women preferring treatment with natural products did so because of the risk of breast cancer associated with HT. HT was recognized by 59% of the women as one of the most important contributors to an increased breast cancer risk. Most women received their information about HT and breast cancer risk from the media. CONCLUSIONS: This European survey reveals that the majority of women experience climacteric symptoms but that their decision whether or not to use HT is highly dependent on their concern about breast cancer risk. An increase in knowledge of the benefits and risks of HT is required for women to make appropriate decisions about hormone use. 相似文献
4.
5.
6.
Jenny Chang-Claude Silke Hermann Ursula Eilber Karen Steindorf 《Cancer epidemiology, biomarkers & prevention》2005,14(4):963-968
BACKGROUND: The long-term observation of vegetarians in affluent countries can provide insight into the relative effects of a vegetarian diet and lifestyle factors on mortality. METHODS: A cohort study of vegetarians and health-conscious persons in Germany was followed-up prospectively for 21 years, including 1,225 vegetarians and 679 health-conscious nonvegetarians. Standardized mortality ratios compared with the German general population were calculated for all causes and specific causes. Within the cohort, Poisson regression modeling was used to investigate the joint effects of several risk factors on overall and cause-specific mortality. RESULTS: Standardized mortality ratios for all-cause mortality was significantly below 100: 59 [95% confidence interval (95% CI), 54-64], predominantly due to a deficit of deaths from circulatory diseases. Within the cohort, vegetarian compared with nonvegetarian diet had no effect on overall mortality [rate ratio (RR), 1.10; 95% CI, 0.89-1.36], whereas moderate and high physical activity significantly reduced risk of death (RR, 0.62, 0.64), adjusted for age, sex, smoking, alcohol intake, body mass index, and educational level. Vegetarian diet was however associated with a reduced RR of 0.70 (95% CI, 0.41-1.18) for ischemic heart disease, which could partly be related to avoidance of meat. CONCLUSIONS: Both vegetarians and nonvegetarian health-conscious persons in this study have reduced mortality compared with the general population. Within the study, low prevalence of smoking and moderate or high level of physical activity but not strictly vegetarian diet was associated with reduced overall mortality. The nonsignificant reduction in mortality from ischemic heart diseases in vegetarians compared with health-conscious persons could be explained in part by avoidance of meat intake. 相似文献
7.
Hermann Welcker 《Virchows Archiv : an international journal of pathology》1878,74(4):500-504
Ohne ZusammenfassungHierzu Taf. XVIII. 相似文献
8.
Sabrina Hundt Ulrike Haug Hermann Brenner 《Cancer epidemiology, biomarkers & prevention》2007,16(10):1935-1953
BACKGROUND: Despite different available methods for colorectal cancer (CRC) screening and their proven benefits, morbidity, and mortality of this malignancy are still high, partly due to low compliance with screening. Minimally invasive tests based on the analysis of blood specimens may overcome this problem. The purpose of this review was to give an overview of published studies on blood markers aimed at the early detection of CRC and to summarize their performance characteristics. METHOD: The PUBMED database was searched for relevant studies published until June 2006. Only studies with more than 20 cases and more than 20 controls were included. Information on the markers under study, on the underlying study populations, and on performance characteristics was extracted. Special attention was given to performance characteristics by tumor stage. RESULTS: Overall, 93 studies evaluating 70 different markers were included. Most studies were done on protein markers, but DNA markers and RNA markers were also investigated. Performance characteristics varied widely between different markers, but also between different studies using the same marker. Promising results were reported for some novel assays, e.g., assays based on SELDI-TOF MS or MALDI-TOF MS, for some proteins (e.g., soluble CD26 and bone sialoprotein) and also for some genetic assays (e.g., L6 mRNA), but evidence thus far is restricted to single studies with limited sample size and without further external validation. CONCLUSIONS: Larger prospective studies using study populations representing a screening population are needed to verify promising results. In addition, future studies should pay increased attention to the potential of detecting precursor lesions. 相似文献
9.
Bergner Raoul; Hoffmann Martin; Riedel Klaus-Dieter; Mikus Gerd; Henrich Dirk M.; Haefeli Walter E.; Uppenkamp Michael; Walter-Sack Ingeborg 《Nephrology, dialysis, transplantation》2006,21(4):1019-1023
To cover intermediate sensitive Candida glabrata in ICU patients,fluconazole plasma peak levels at least in the range of 1632µg/ml appear necessary for treatment. Previous studiesdid not reach these fluconazole levels under continuous veno-venoushaemofiltration (CVVHF) with dosages of 200600 mg fluconzoledaily. In the present study, nine patients simultaneously requiringCVVHF for treatment of acute oligoanuric renal failure and antimycotictherapy of Candida septicemia received fluconazole 800 mg/day.Fluconazole plasma levels were determined to evaluate whetherthis dosage is adequate to reach the advised fluconazole levels.Patients were dialysed on two consecutive days with an ultrafiltrationrate (UF) of 1000 ml/h or 2000 ml/h, respectively, in a randomizedorder. The predilution was 800 ml/h and 1800 ml/h, respectively.The treatment was tolerated without adverse effects. All patientsreached plasma fluconazole concentrations between 16 and 32µg/ml, remaining in this range for a minimum of 1 up to24 h with a mean of 9.6 h and a UF rate of 2000 ml/h, and 15.7h with a UF rate of 1000 ml/h. So far, there are no in vivodata on the fluconazole plasma concentrations required for effectivetreatment. However, our data demonstrate, that at least thefluconazole concentrations desirable on the basis of in vitrosusceptibility testing can be reached in critically ill patientson CVVHF in an ICU setting. However, in these patients, 800mg fluconazole/day are necessary to achieve fungicidal drugconcentrations. 相似文献
10.
L. Hermann 《Pflügers Archiv : European journal of physiology》1878,16(1):191-262
Ohne Zusammenfassung 相似文献